DFX Intelligence
Venture Capital Intelligence
Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.
The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.
Companies / C••• T••••••••• H•••••••• I•••
C••• T••••••••• H•••••••• I•••
Stage unknownSouth San Francisco, CAPharmaceuticals
Facts
Financing history
2 rounds
- Apr 22, 2025Form D equity offering · $5.0M (form d sold) · 5 investorsFact SEC EDGAR Form D data sets (quarterly) · “C••• T••••••••• H•••••••• I••• filed Form D: $5,000,000 sold of $8,000,000, Pharmaceuticals”
- Sep 26, 2024Form D equity offering · $1.3M (form d sold) · 13 investorsFact SEC EDGAR Form D data sets (quarterly) · “C••• T••••••••• H•••••••• I••• filed Form D: $1,250,000 sold of $1,250,000, Pharmaceuticals”
Investors on record
1 edges
- V•••••• V•••••• M••••••••• L•• board only, B•••• G• A••••• (strongly supported) Inference sec.gov
People
4 officers, 9 directors
- A••••• A••••• K••••••••• Chief Financial Officer sec.gov
- C•••• A••••• E•••••• Interim Chairman and CEO sec.gov
- C•••• E•••••• Chairman and Chief Executive Officer sec.gov
- K•••••• A••••• P••••• Chief Development Officer sec.gov
- M•••••• A••••• B••••• Director Fact
- B•••• A••••• CEO at time of agreement, now former CEO but a continuing director Fact
- L•••••• A••••• R•••• Director Fact
- K••••••• A••••• L•••••• Director Fact
- B•••• G• A••••• Director Inference
- L•••••• G• R•••• Director Fact
- K••••••• G• L•••••• Director Fact
- S•••• G• P•••• Director Fact
- M•••••• G• B••••• Director Fact
Timeline
2
- May 6, 2025C••• T••••••••• H•••••••• I••• filed Form D: $5,000,000 sold of $8,000,000, PharmaceuticalsForm D filed Fact SEC EDGAR Form D data sets (quarterly)
- Oct 4, 2024C••• T••••••••• H•••••••• I••• filed Form D: $1,250,000 sold of $1,250,000, PharmaceuticalsForm D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
30 observations
Every observation on this company
- Entity type: Corporation May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Entity type: Corporation Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Pharmaceuticals May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Form D industry group: Pharmaceuticals Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amendment: false Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): No Revenues May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Revenue range (Form D): No Revenues Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Incorporated: withinFiveYears Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Jurisdiction: DELAWARE Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $5.0M May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Amount sold (Form D): $1.3M Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $8.0M May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Offering amount (Form D): $1.3M Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Exemptions: 06b Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2025-04-22 May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- First sale: 2024-09-26 Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 5 May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Investors (Form D): 13 Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 0 May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Minimum investment (Form D): 1,000 Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Securities offered: equity,option Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA, 94080 May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Office address: 201 HASKINS WAY, SUITE 230, SOUTH SAN FRANCISCO, CA, 94080 Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2021 May 6, 2025 Fact SEC EDGAR Form D data sets (quarterly)
- Year of incorporation: 2021 Oct 4, 2024 Fact SEC EDGAR Form D data sets (quarterly)